Pfizer

Amgen to buy Pfizer plant, saving 280 jobs

Friday, March 11, 2011 01:53 PM

Amgen has agreed to buy a Pfizer manufacturing plant at Dun Laoghaire, County Dublin, securing 280 jobs in the process. The transaction is expected to close in the second quarter of the year, according to Fierce Pharma.

More... »

Pfizer’s new RA clears phase III

Tuesday, March 8, 2011 10:51 AM

Pfizer has reported data from its phase III trial of its oral JAK inhibitor tofacitinib, which underwent a name change from tasocitinib. The drug hit its primary endpoint for statistical significance among patients with rheumatoid arthritis. The experimental therapy, one of Pfizer's biggest late-stage prospects, was shown to improve symptoms of RA. Full data will be forthcoming.

More... »

Xiapex approved for use in Europe

Monday, March 7, 2011 07:31 AM

Xiapex (collagenase clostridium histolyticum), a non-surgical treatment for Dupuytren’s contracture in adult patients with a palpable cord, has been granted marketing authorization by the European Commission and should available for use in some European markets later this year. 

More... »

Charles River, Pfizer collaborate

Friday, March 4, 2011 02:19 PM

Charles River Laboratories has signed a marketing and distribution agreement with Pfizer to provide certain Pfizer-developed genetically modified research models to the global biomedical research community. Under this agreement, CRL will supply a number of pre-competitive, transgenic research models developed by Pfizer across a broad range of therapeutic areas, including neuroscience, diabetes and cardiovascular disease.

More... »

Pfizer cuts 15 R&D projects, buys King

Wednesday, March 2, 2011 12:56 PM

Pfizer has cut its R&D pipeline again, removing 15 experimental projects in a bid to restructure its operations and conserve earnings, according to PharmaTimes. 

More... »

NicOx to appeal FDA rejection

Tuesday, March 1, 2011 08:30 AM

French biotech NicOx said last week it plans to appeal the FDA’s decision to turn down its anti-inflammatory drug naproxcinod for marketing approval, Reuters reported. NicOx made the announcement at its 2010 earnings presentation.

More... »

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Monday, February 7, 2011 07:00 AM

A billion-dollar U.S. government drug development center, which will focus on moving potential new discoveries out of the lab and into early-phase trials, could help biopharmaceutical companies improve their success rate in developing new treatments by reducing the risk of failure in early-stage research.

More... »

Pfizer cuts jobs in Connecticut, adds in Massachusetts

Tuesday, February 1, 2011 04:18 PM

Boston Business Journal staff report

More... »

ProPublica report: big pharma paid hundreds of physicians over $100,000 in speaking fees

Monday, November 8, 2010 11:12 AM

Several doctors paid to speak on behalf of big pharmaceutical companies aren’t, in fact, the thought leaders consumers often consider them to be, but instead have been sanctioned for various forms of misconduct. And psychiatrists collect more in speaking and consulting fees from pharma companies than doctors in any other specialty.

More... »

ClinTec International launches US headquarters

Friday, July 9, 2010 07:29 AM

Glasgow, U.K.-based global clinical research organization ClinTec International has unveiled a significant expansion into the U.S., with the launch of its New York office and the appointment of Susan Pavone as Associate Director of U.S. Business Operations.

More... »